Insulin buccal

Published

dm+d

Unassigned

New Medicines

Oral-lynType 1 and 2 diabetes mellitus

Information

Oral-lyn
New molecular entity
Generex
Generex

Development and Regulatory status

None
None
None

Category

Regular human insulin administered to the buccal mucosa using the RapidMist device
In 2011 the UK prevalence of diabetes was 4.45% (about 2.9 million people). It is thought a further 850,000 are undiagnosed. The prevalence is projected to increase to 5 million people by 2025. About 90% of people with diabetes have type 2 disease.
Type 1 and 2 diabetes mellitus
Buccal

Further information

Yes

Trial or other data

Nov 21Company do not have adequate finances to proceed with trials [31].